Benralizumab for Uncontrolled Asthma in Adolescents

In this video, William Busse, MD, discusses the results of his study on the effectiveness of treatment with benralizumab in adolescent patients with uncontrolled asthma.

Additional Resource:

  • Busse W, Bleecker E, FitzGerald JM, et al. Three-year safety and efficacy of benralizumab for adolescent patients with severe, uncontrolled asthma: results of the BORA extension study. JACI. 2020;145(2)Supp AB174. DOI:https://doi.org/10.1016/j.jaci.2019.12.363

William Busse, MD, is a professor of allergy and immunology in the Clinical Science Center at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin.

Submit Feedback

Name